FIGURE 3.

Primary versus metastatic studies for all indications evaluated demonstrated >50% OA. In addition, NSCLC, TNBC CPS≥10, HNSCC CPS ≥1, and GC/GEJ, demonstrated >85% OA. CPS indicates Combined Positive Score; EC, esophageal cancer; GC/GEJ, gastric or gastroesophageal junction; HNSCC, head and neck squamous cell carcinoma; IHC, immunohistochemical; NSCLC, non–small cell lung carcinoma; OA, overall percent agreement; PD-L1, programmed cell death ligand-1; TNBC, triple negative breast cancer; TPS, tumor proportion score; UC, urothelial carcinoma.